Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 8Neoplasms 3Hemangioma, Capillary 2Anxiety Disorders 2Weight Loss 1Vomiting 1Urinary Incontinence, Stress 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Shoulder Pain 1Respiratory Aspiration 1Psychomotor Agitation 1Prostatic Neoplasms 1Premature Birth 1Polycystic Ovary Syndrome 1Pediatric Obesity 1Pancreatic Neoplasms 1Pain, Postoperative 1Ovarian Cysts 1Obesity 1Neuromuscular Diseases 1Neuroblastoma 1Nasopharyngeal Carcinoma 1Myofibroma 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Multiple Myeloma 1Menstruation Disturbances 1Lymphoma, Follicular 1Lung Neoplasms 1

Interventions

Timolol 7Propranolol 6Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hemangioma, Capillary × Population Groups × Clear all
NCT01147601 2017-07-05

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

Oregon Health and Science University

Phase EARLY_PHASE1 Terminated
6 enrolled 7 charts

Hemangioma, Hemangioma, Capillary

NCT01434849 2016-11-15

TiPPIH

The University of Texas Health Science Center at San Antonio

Phase 1 Terminated
26 enrolled

Hemangioma, Capillary, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡